タンパク質、抗体、アッセイキット
タンパク質カタログ
輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。
- サプライヤー
- AcroBioSystems
- カタログNo.
- HLL-H82E3
- 製品名称
- Biotinylated Human HLA-A*02:01&B2M&Vaccinia virus (SLSNLDFRL) Complex Protein (Monomer, MALS verified)
- タンパク質名
- HLA-A*0201 & B2M & Vaccinia virus (SLSNLDFRL)
- Species
- Human
- HOST
- HEK293
Overview
| Synonyms | - |
|---|---|
| Characteristics | Biotinylated Human HLA-A*02:01&B2M&Vaccinia virus (SLSNLDFRL) Complex Protein is produced by co-expression of HLA and B2M loaded with Vaccinia virus peptide. This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag?). The protein has a calculated MW of 36.3 kDa and 11.7 kDa. The protein migrates as 40-43 kDa and 10 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation. |
| Endotoxin Level | N/A |
| Purity | 90% |
| Description | Among the nonvirion proteins of the vaccinia virus (VACV), a 94-kDa long protein is most abundantly present; the protein is a truncated form of the 150-kDa A-type inclusion (ATI) protein of the cowpox virus encoded by the ati gene. This VACV protein does not form intracellular ATIs, being as it is a major immunogen upon infection/immunization of humans or animals with the VACV. variants demonstrated that the mutant LIVPΔati elicits a stronger protective response compared to the parent LIVP. The human HLA-A*0201 Vaccinia virus F11L (SLSNLDFRL) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and SLSNLDFRL peptide of the vaccinia virus. |
| Reference | - |
| URL | https://www.acrobiosystems.com/products/protein/hla-a-0201-b2m-vaccinia-virus-slsnldfrl-human-hll-h82e3 |

検索
お問い合わせリスト